Commerzbank Aktiengesellschaft’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Commerzbank Aktiengesellschaft's REGN Position: Q2 2026 in Review
Commerzbank Aktiengesellschaft reduced its Regeneron Pharmaceuticals (REGN) stake by 6.1% in Q2 2026, selling an estimated $22.5K and leaving 506 shares worth $316K. The position accounts for 0.01% of the portfolio, ranked #297.
Commerzbank Aktiengesellschaft first reported a position in REGN in Q2 2013 and has held it in 37 quarters since. The position peaked at $33.9M in Q2 2015. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Commerzbank Aktiengesellschaft held 506 shares of Regeneron Pharmaceuticals worth $316K as of Q2 2026.
- Commerzbank Aktiengesellschaft sold 33 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $22.5K.
- Regeneron Pharmaceuticals made up 0.01% of Commerzbank Aktiengesellschaft's portfolio in Q2 2026, its #297 holding.
- Commerzbank Aktiengesellschaft first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 37 quarters since.
- Commerzbank Aktiengesellschaft's Regeneron Pharmaceuticals position peaked at $33.9M in Q2 2015.
- 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Commerzbank Aktiengesellschaft's 13F filing for Q2 2026, filed 7 Aug 2026.